Shares of Procter & Gamble Rise on Earnings

Written by Haley Alber

et|icon_calendar|

October 22, 2019

et|icon_grid-3×3|

Shares of Procter & Gamble Co. (NYSE: PG) opened 4% higher on Tuesday after the company reported better-than-expected first quarter 2020 earnings and revenue.

The maker of Bounty paper towels and Tide detergent said net sales rose 7% to USD 17.80 Billion, topping expectations of USD 17.42 Billion. Adjusted earnings came in at USD 1.37 per share versus Wall Street’s call for USD 1.24 per share.

P&G’s Beauty segment recorded the strongest growth this past quarter, gaining 10% thanks to a rise in skin care and hair care sales. The company’s Healthcare, Home, and Family Care segments also recorded notable organic sales growth of 9%, 8%, and 5% respectively. Procter & Gamble’s shaving segment this past quarter grew sales by only 1% year-over-year as its Gillette shaving business continues to drag.

“We delivered strong top-line growth, profit margin expansion and cash productivity in the first quarter, enabling us to increase our outlook for fiscal year results,” said David Taylor, Chairman, President and Chief Executive Officer. “We will continue executing our strategies of superiority, productivity, constructive disruption and improving P&G’s organization and culture to deliver balanced top-line and bottom-line growth along with strong cash generation in a challenging competitive and macroeconomic environment.”

P&G raised its outlook for fiscal 2020 all-in sales growth from a range of 3% to 4% to a range of 3% to 5% growth compared with the prior fiscal year. The company also said it now expects its core earnings per share to grow between 4% and 10% in fiscal 2020, ahead of its original expectations of 4% to 9% growth.

Stock price

DAY LOW/HIGH

52 week low/high

Comparables

Related Articles

Sanofi Acquires Synthrox for USD 2.5 Billion

Sanofi Acquires Synthrox for USD 2.5 Billion

Healthcare & Biotechs0 Comments Sanofi (NASDAQ: SNY) announced on Monday that it has acquired Synthorx (NASDAQ: THOR) for USD 2.5 Billion to boost its immuno-oncology pipeline. Synthorx shares surged by 169% at the open on Monday. Synthorx is...

Novartis to Buy The Medicines Co. for USD 9.7 Billion

Novartis to Buy The Medicines Co. for USD 9.7 Billion

Healthcare & Biotechs0 Comments Swiss pharmaceutical company Novartis AG (NYSE: NVS) on Sunday said it will buy cholesterol-drug maker The Medicines Company (NASDAQ: MDCO) for USD 9.7 Billion. Shares of The Medicines Company shot up about 22%...

Planet Fitness (NYSE: PLNT) Jumps After Sales Beat Expectations

Planet Fitness (NYSE: PLNT) Jumps After Sales Beat Expectations

Healthcare & Biotechs0 Comments Planet Fitness, Inc. (NYSE: PLNT) stock jumped about 10% after the franchisee and operator of fitness centers reported financial results for its third quarter ended September 30, 2019.  Third Quarter Fiscal...

Comments

Leave a Reply

avatar
  Subscribe  
Notify of